CGS.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 02:10):

Stats
Today's Volume	44 521.00
Average Volume	101 636
Market Cap	222.84M
EPS	$0 ( 2024-02-25 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	26.00
ATR14	$0.0120 (0.94%)

CogState Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CogState Ltd Financials

Annual	2023
Revenue:	$60.14M
Gross Profit:	$12.29M (20.43 %)
EPS:	$0.0306

Q2	2023
Revenue:	$27.68M
Gross Profit:	$3.60M (13.00 %)
EPS:	$0.0176

Q4	2023
Revenue:	$34.07M
Gross Profit:	$11.58M (33.99 %)
EPS:	$0.0299

Q3	2022
Revenue:	$15.64M
Gross Profit:	$8.72M (55.74 %)
EPS:	$0.0135

Financial Reports:

No articles found.

CogState Ltd

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.